A specific M&A theme focused on accelerating product rollout and business growth in Japan and overseas by making Bolt Medical a wholly owned subsidiary and bringing in its research, development and manufacturing capabilities for medical devices used in endovascular cerebrovascular treatment. This also includes market penetration through training and adoption of the Medilizer AGD system.